iBio (IBIO) Net Margin Growth (3y) (2014 - 2024)
iBio (IBIO) Net Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -260,010.00 |
| Sep 30, 2023 | 50,941.00 |
| Mar 31, 2022 | 12,514.00 |
| Sep 30, 2021 | 366,524.00 |
| Jun 30, 2021 | 493,676.00 |
| Mar 31, 2021 | 415,173.00 |
| Dec 31, 2020 | 142,858.00 |
| Sep 30, 2020 | 133,675.00 |
| Jun 30, 2020 | 266,674.00 |
| Mar 31, 2020 | 570,740.00 |
| Dec 31, 2019 | -377,970.00 |
| Sep 30, 2019 | -192,611.00 |
| Jun 30, 2019 | 39,886.00 |
| Mar 31, 2019 | -1,242.00 |
| Dec 31, 2018 | 98,413.00 |
| Sep 30, 2018 | -878,812.00 |
| Jun 30, 2018 | -432,732.00 |
| Mar 31, 2018 | -471,340.00 |
| Dec 31, 2017 | -190,202.00 |
| Sep 30, 2017 | -300,250.00 |